5 02, 2016

FGEP and other Latin American organizations requested a Thematic Hearing at the Inter-American Commission on Human Rights

2018-02-05T10:36:13-03:00viernes, 5 febrero, 2016|Advocacy, Direct Action, Hepatitis C, HIV, Medicines, Public Health, RedLAM|

Por: Julia Varela   GEP Foundation (FGEP), along with more than 20 other civil society organizations from different countries in Latin America committed to defending the right to health, requested last January 18th a Thematic Hearing at the Inter-American Commission on Human Rights (IACHR) on the issue of lack of access to medicines. The request

4 11, 2015

Argentina could save U$11M per year buying generic version of Truvada®

2015-11-04T20:01:06-03:00miércoles, 4 noviembre, 2015|Access to Medicines, Advocacy, Health Safeguards, Intellectual Property, Patent opposition|

The Argentine Community of People Living with HIV requested the rejection of a patent for an essential HIV/AIDS medicine. If the Argentine Patent Office does grant the this request, Argentina could produce generic versions at a lower cost representing a potential saving of over US$11 million. Argentina April 13th, 2015.- The Grupo Efecto Positivo Foundation (FGEP) in collaboration with the Argentine

29 07, 2015

World Viral Hepatitis Day: Challenges and Progress in Argentina for access to treatments that cure

2015-11-04T14:06:31-03:00miércoles, 29 julio, 2015|Access to Medicines, Advocacy, Hepatitis C, Intellectual Property, Ministry of Health, Public Health|

BUENOS AIRES - On World Viral Hepatitis Day, Fundación Grupo Efecto Positivo (FGEP) held a meeting with officials from Argentina’s Ministry of Health, articulating and coordinating actions and strategies that promote access to sofosbuvir, an essential drug for Hepatitis C treatment. The need for joint action originates from the great challenge both Argentina and Latin

20 05, 2015

Patent opposition for Sofosbuvir requested in Argentina

2015-11-04T16:41:16-03:00miércoles, 20 mayo, 2015|Access to Medicines, Advocacy, Health Safeguards, Hepatitis C, Public Health|

Organizations of people with hepatitis C have filed an opposition for a patent that would prevent 800,000 people from having access to treatment in Argentina Fundación Grupo Efecto Positivo (FGEP) leads the opposition to pharmaceutical patents movement as a key strategy to ensure access to medicines The growing global movement to guarantee access to medicines

Ir a Arriba